Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01177670 · ClinicalTrials.gov registry record
Adiana Post-Approval Clinical Study (APACS)
A clinical trial, sponsored by Hologic.
- Terminated
- Registry status
- 169
- Enrollment target
NCT01177670: Clinical Trial study, sponsored by Hologic.
NCT01177670 is a clinical trial that was terminated before completion, run by Hologic. The registered enrollment target is 169 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01177670 was terminated before completion, sponsored by Hologic.
- TERMINATED
- Registry status
- 169 participants
- Enrollment target
Study Summary
The Adiana Post-Approval Clinical Study (APACS) has been designed to compile information on the efficacy and safety of the Adiana Permanent Contraception System in the post market setting. Specifically, data will be collected that is relevant to the evaluation of the safety and efficacy of the Adiana System for women who desire permanent birth control by occlusion of the fallopian tubes. This study is an observational study that is not intended to test specific hypotheses.
Primary Outcome
The primary efficacy endpoints are the one and two year pregnancy rates among women who have hysterosalpingogram (HSG)-proven bilateral occlusion and are informed that they may rely on the Adiana System for contraception.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 169 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-04 |
Why NCT01177670 stopped before completion
NCT01177670 is an observational study that tracks outcomes without assigning an intervention. The registered 169 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01177670 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01177670 about?
NCT01177670 is a clinical study titled "Adiana Post-Approval Clinical Study (APACS)". The Adiana Post-Approval Clinical Study (APACS) has been designed to compile information on the efficacy and safety of the Adiana Permanent Contraception System in the post market setting. Specifically, data will be collected that is relevant to the evaluation of the safety and efficacy of the Adian...
What is the current status of trial NCT01177670?
This trial is currently terminated. The enrollment target is 169 participants. The study started on 2010-08. Estimated completion is 2012-04.
Who is sponsoring clinical trial NCT01177670?
This trial is sponsored by Hologic, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06191484 · 169 participants · NA
Risk and Resilience to Suicide Following Late-Life Spousal Bereavement
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia